Home / 2013 (page 4)

Yearly Archives: 2013

Many Diabetes Patients Choose Secure Messaging But Few Are Responsive

In a recent study, secure messaging was the most popular choice for diabetes patients in post education programs, followed by in-person and phone-based interventions. However, fewer patients in the secure messaging arm finished the intervention compared with the other group, researchers found. The complexity of secure messaging may have played …

Read More »

Insulin Glargine U300 versus Lantus

New preliminary data is in…. Sanofi, the maker of Lantus (insulin glargine), finished more phase III studies on their newest formulation of insulin glargine, U300, and discussed their results at the World Diabetes Congress 2013 in early December. The study results have not yet been published but researchers reported that the …

Read More »